Zhou Wang

机构：University of Pittsburgh, Shenzhen Center for Disease Control and Prevention, UPMC Hillman Cancer Center, First People's Hospital of Chongqing · ORCID：0000-0002-1604-4767

发表论文 365 篇 · 总被引 5725 次 · h-index 41

代表论文

• Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives- (2024 · International Neurourology Journal · 被引 48)
• Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study (2024 · Journal for ImmunoTherapy of Cancer · 被引 26)
• Preoperative neoadjuvant targeted therapy remodels intra-tumoral heterogeneity of clear-cell renal cell carcinoma and ferroptosis inhibition induces resistance progression (2024 · Cancer Letters · 被引 24)
• Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT/mTOR signaling pathway (2023 · Cancer Cell International · 被引 23)
• Androgen receptor inhibitors in treating prostate cancer (2024 · Asian Journal of Andrology · 被引 12)
• The value of shear wave elastography combined with red blood cell distribution width in evaluating arterial erectile dysfunction (2024 · BMC Urology · 被引 11)